U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


Chappel Scott C (0001551615)
Mailing Address
C/O OVASCIENCE, INC.
41 LINSKEY WAY, LEVEL B
CAMBRIDGE MA 02142
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
Surface Oncology, Inc. 0001718108 2018-04-18 officer: Chief Technology Officer
Tempest Therapeutics, Inc. 0001544227 2012-06-11 officer: VP and CSO


Items 1 - 6

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name
- -   OvaScience, Inc. 3 - --D 1 0001544227 Stock Option
- -   Surface Oncology, Inc. 3 - --D 162566.0000 1 0001718108 Common Stock
- -   Surface Oncology, Inc. 3 - --D 2 0001718108 Stock Option (Right to Buy)
- -   Surface Oncology, Inc. 3 - --D 3 0001718108 Stock Option (Right to Buy)
- -   Surface Oncology, Inc. 3 - --D 4 0001718108 Stock Option (Right to Buy)
- -   Surface Oncology, Inc. 3 - --D 5 0001718108 Stock Option (Right to Buy)

http://www.sec.gov/cgi-bin/own-disp


Modified: 04/22/2016